Quantinno Capital Management LP Grows Stake in Agilent Technologies, Inc. (NYSE:A)

Quantinno Capital Management LP increased its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 28.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 69,211 shares of the medical research company's stock after purchasing an additional 15,533 shares during the quarter. Quantinno Capital Management LP's holdings in Agilent Technologies were worth $10,277,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the business. Quarry LP lifted its position in Agilent Technologies by 535.1% in the third quarter. Quarry LP now owns 3,550 shares of the medical research company's stock valued at $527,000 after purchasing an additional 2,991 shares during the last quarter. Ilex Capital Partners UK LLP purchased a new position in shares of Agilent Technologies in the third quarter worth $33,087,000. Investment Management Corp of Ontario raised its holdings in Agilent Technologies by 47.1% during the 3rd quarter. Investment Management Corp of Ontario now owns 9,681 shares of the medical research company's stock valued at $1,437,000 after buying an additional 3,100 shares during the last quarter. HighTower Advisors LLC boosted its position in Agilent Technologies by 2.1% during the 3rd quarter. HighTower Advisors LLC now owns 66,981 shares of the medical research company's stock valued at $9,907,000 after buying an additional 1,349 shares during the period. Finally, Hilltop Holdings Inc. purchased a new stake in Agilent Technologies during the 3rd quarter valued at $5,714,000. 87.42% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. StockNews.com cut shares of Agilent Technologies from a "buy" rating to a "hold" rating in a research report on Tuesday, November 26th. Barclays reduced their price target on Agilent Technologies from $145.00 to $135.00 and set an "underweight" rating on the stock in a report on Wednesday, November 27th. Wells Fargo & Company initiated coverage on Agilent Technologies in a report on Tuesday, August 27th. They issued an "overweight" rating and a $157.00 price objective for the company. TD Cowen boosted their target price on Agilent Technologies from $153.00 to $160.00 and gave the company a "buy" rating in a research note on Thursday, August 22nd. Finally, JPMorgan Chase & Co. dropped their price target on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a research note on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $143.40.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares in the company, valued at approximately $5,801,595. This trade represents a 19.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.33% of the stock is owned by insiders.

Agilent Technologies Stock Up 2.0 %

NYSE A traded up $2.70 during trading hours on Friday, reaching $140.57. 1,297,596 shares of the company's stock traded hands, compared to its average volume of 1,728,390. The firm has a market cap of $40.39 billion, a PE ratio of 31.80, a PEG ratio of 4.42 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. Agilent Technologies, Inc. has a 52-week low of $124.16 and a 52-week high of $155.35. The firm has a 50-day simple moving average of $137.38 and a 200 day simple moving average of $136.97.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.05. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The firm had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the business earned $1.38 earnings per share. The business's revenue was up .8% on a year-over-year basis. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.56 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This is an increase from Agilent Technologies's previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a dividend yield of 0.71%. Agilent Technologies's dividend payout ratio (DPR) is presently 22.40%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.